Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin.

Dillon SR, Harder B, Lewis KB, Moore MD, Liu H, Bukowski TR, Hamacher NB, Lantry MM, Maurer M, Krejsa CM, Ellsworth JL, Pederson S, Elkon KB, Wener MH, Dall'Era M, Gross JA.

Arthritis Res Ther. 2010;12(2):R48. doi: 10.1186/ar2959. Epub 2010 Mar 19.

2.

The uncertain glory of APRIL.

Medema JP, Planelles-Carazo L, Hardenberg G, Hahne M.

Cell Death Differ. 2003 Oct;10(10):1121-5. Review.

3.

The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.

Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F.

Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15. doi: 10.1016/j.cytogfr.2013.04.003. Epub 2013 May 15. Review.

PMID:
23684423
4.
5.

Anticytokine therapy impacting on B cells in autoimmune diseases.

Daridon C, Burmester GR, Dörner T.

Curr Opin Rheumatol. 2009 May;21(3):205-10. doi: 10.1097/BOR.0b013e32832a0760. Review.

PMID:
19346949
6.

BAFF, APRIL and their receptors: structure, function and signaling.

Bossen C, Schneider P.

Semin Immunol. 2006 Oct;18(5):263-75. Epub 2006 Aug 17. Review.

PMID:
16914324
7.

[The role of BAFF in autoimmune diseases].

Matsushita T, Sato S.

Nihon Rinsho Meneki Gakkai Kaishi. 2005 Oct;28(5):333-42. Review. Japanese.

8.

BLyS and B cell homeostasis.

Woodland RT, Schmidt MR, Thompson CB.

Semin Immunol. 2006 Oct;18(5):318-26. Epub 2006 Aug 22. Review.

PMID:
16931037
9.

The BAFF/APRIL system: life beyond B lymphocytes.

Ng LG, Mackay CR, Mackay F.

Mol Immunol. 2005 May;42(7):763-72. Epub 2004 Dec 8. Review.

PMID:
15829264
10.

Mechanism of BLyS action in B cell immunity.

Do RK, Chen-Kiang S.

Cytokine Growth Factor Rev. 2002 Feb;13(1):19-25. Review.

PMID:
11750877
11.

[Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis].

Hartung HP.

Nervenarzt. 2009 Dec;80(12):1462-72. doi: 10.1007/s00115-009-2838-6. Review. German.

PMID:
19779889
12.

[Progress in the study of BLyS and APRIL on regulating T cell responses in rheumatoid arthritis].

Chang Y, Wei W.

Yao Xue Xue Bao. 2013 Jul;48(7):979-85. Review. Chinese.

PMID:
24133964
13.

Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.

Jelinek DF, Darce JR.

Curr Dir Autoimmun. 2005;8:266-88. Review.

PMID:
15564725
14.

The role of APRIL and BAFF in lymphocyte activation.

Schneider P.

Curr Opin Immunol. 2005 Jun;17(3):282-9. Review.

PMID:
15886118
15.
16.

BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.

Treml LS, Crowley JE, Cancro MP.

Semin Immunol. 2006 Oct;18(5):297-304. Epub 2006 Aug 17. Review.

PMID:
16919470
17.

The TNF family members BAFF and APRIL: the growing complexity.

Mackay F, Ambrose C.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):311-24. Review.

PMID:
12787568
18.
19.

Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers.

Dörner T, Kinnman N, Tak PP.

Pharmacol Ther. 2010 Mar;125(3):464-75. doi: 10.1016/j.pharmthera.2010.01.001. Epub 2010 Jan 25. Review.

PMID:
20097226
20.

Supplemental Content

Support Center